Joel Schlessinger M.D.

Joel Schlessinger MD recently administered a study at the Advanced Skin Research Center researching the effectiveness of treating Hidradenitis suppurativa with adalimumab. This study was published in the Annals of Internal Medicine under the title “Adalimumab for the Treatment of Hidradenitis Suppurativa.” Hidradentitis supperativa is a chronic skin condition that causes draining and foul-smelling areas […]

Joel Schlessinger MD recently reviewed a study on the treatment of actinic keratosis. The study, “Ingenol Mebutate Gel 0.015% and 0.05% in Actinic Keratosis,” was published in the 2012 issue of Drugs. Actinic keratosis is characterized by small, rough, raised patches that are found on areas of skin that have had prolonged exposure to the […]

Joel Schlessinger MD recently administered a study on the treatment of acne vulgaris with the use of adapalene 0.1% lotion. This study was published in the Journal of Drugs in Dermatology titled, “Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.” Acne vulgaris affects roughly 15 […]

Joel Schlessinger administered a study, along with other dermatology professionals, examining the safety and efficacy of dapsone gel 5% in the treatment of moderate acne vulgaris when used in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer. This study, “Dapsone Gel 5% in Combination with Adapalene Gel 0.1%, Benzoyl Peroxide Gel 4% […]